Vancomycin is the primary antibiotic administered for treatment of methicillinresistant S. aureus (MRSA) infection; however, treatment failure of vancomycin is currently not uncommon in patients with in vitro vancomycin susceptibile S. aureus (MIC ≤ 2 μg/mL) infection. In this report, we describe a case of septic arthritis caused by persistent MRSA bacteremia and treated successfully with linezolid after failure of initial vancomycin therapy.
All Science Journal Classification (ASJC) codes
- Infectious Diseases
- Pharmacology (medical)